The United States Food and Drug Administration grants Mindmaze clearance for MindMotion Pro

The United States Food and Drug Administration grants Mindmaze clearance for MindMotion Pro

17.05.2017 – Medtech startup MindMaze working at the intersection of neuroscience and virtual reality, announces that the United States Food and Drug Administration (FDA) has granted it clearance. This allows Mindmaze to market their MindMotion PRO in the United States. Mindmaze also completed clinical trials of their a portable neurotechnology device MindMotion GO.

Read more…